CMS Hyperbaric Oxygen Therapy Coverage Policy Update (NCD 20.29): What Billing Teams Need to Know for 2026
CMS has modified its National Coverage Determination for hyperbaric oxygen (HBO) therapy under NCD 12, with an effective date of March 12, 2026. This policy governs which conditions qualify for Medicare reimbursement when HBO is administered in a chamber setting—and the covered versus noncovered distinctions are strict, specific, and frequently misunderstood by billing teams. If your facility provides HBO therapy, this update warrants an immediate review of your documentation protocols and medical necessity criteria.
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Hyperbaric Oxygen Therapy |
| Policy Code | NCD 12 |
| Change Type | Modified |
| Effective Date | 2026-03-12 |
| Impact Level | High |
| Specialties Affected | Wound care, vascular surgery, infectious disease, orthopedic surgery, radiation oncology, emergency medicine, plastic surgery |
| Key Action | Audit active HBO cases against the updated covered conditions list and confirm diabetic wound cases meet all three required Wagner criteria before submitting claims. |
What CMS Covers Under the HBO Therapy NCD
CMS defines hyperbaric oxygen therapy for Medicare coverage purposes as a modality in which the entire body is exposed to oxygen under increased atmospheric pressure, administered in a chamber (including single-person units). This is not a blanket coverage policy—reimbursement is tightly limited to 15 specific conditions.
The covered conditions under NCD 12 are:
- Acute carbon monoxide intoxication
- Decompression illness
- Gas embolism
- Gas gangrene
- Acute traumatic peripheral ischemia (adjunctive, when loss of function, limb, or life is threatened)
- Crush injuries and suturing of severed limbs (adjunctive, when loss of function, limb, or life is threatened)
- Progressive necrotizing infections (necrotizing fasciitis)
- Acute peripheral arterial insufficiency
- Preparation and preservation of compromised skin grafts (not for primary wound management)
- Chronic refractory osteomyelitis, unresponsive to conventional medical and surgical management
- Osteoradionecrosis as an adjunct to conventional treatment
- Soft tissue radionecrosis as an adjunct to conventional treatment
- Cyanide poisoning
- Actinomycosis—adjunctive only, when refractory to antibiotics and surgical treatment
- Diabetic wounds of the lower extremities (see specific criteria below)
Several of these indications require HBO to be used as adjunctive therapy—meaning it cannot be billed as a standalone treatment. Documentation must reflect that accepted standard therapeutic measures are being used concurrently.
CMS Medical Necessity Criteria for Diabetic Wound HBO Coverage
Diabetic lower extremity wounds represent the highest-volume indication for HBO therapy in most wound care centers, and they carry the most detailed—and most litigated—coverage criteria in this NCD. CMS requires that all three of the following criteria be met simultaneously:
| # | Covered Indication |
|---|---|
| 1 | Diabetes diagnosis: The patient has type I or type II diabetes with a lower extremity wound that is attributable to diabetes. |
| 2 | Wagner grade: The wound is classified as Wagner grade III or higher. |
| 3 | Standard wound therapy failure: The patient has failed an adequate course of standard wound therapy. |
"Failure" is not a subjective judgment. CMS defines it as no measurable signs of healing for at least 30 consecutive days of standard wound care treatment. Standard wound care, as defined by the policy, includes all of the following:
| # | Covered Indication |
|---|---|
| 1 | Assessment of vascular status and correction of any vascular problems in the affected limb if possible |
| 2 | Optimization of nutritional status |
| 3 | Optimization of glucose control |
| 4 | Debridement by any means to remove devitalized tissue |
| 5 | Maintenance of a clean, moist granulation tissue bed with appropriate moist dressings |
| 6 | Appropriate off-loading |
| 7 | Treatment to resolve any active infection |
This is not a checklist you can document retroactively. Each element must be reflected in the clinical record before HBO therapy begins.
Ongoing coverage is not automatic. Once HBO therapy starts, wounds must be evaluated at least every 30 days. If measurable signs of healing have not been demonstrated within any 30-day treatment period, continued HBO therapy is not covered. Billing teams should flag any active HBO cases that are approaching a 30-day evaluation window without documented healing progress—those claims are at significant audit risk.
What CMS Will Not Cover: The Noncovered Conditions List
CMS is explicit: all conditions not listed under the covered section are excluded from Medicare payment. The policy enumerates 12 specific noncovered conditions to remove any ambiguity:
- Cutaneous, decubitus, and stasis ulcers
- Chronic peripheral vascular insufficiency
- Anaerobic septicemia and infection other than clostridial
- Skin burns (thermal)
- Senility
- Myocardial infarction
- Cardiogenic shock
- Sickle cell anemia
- Acute thermal and chemical pulmonary damage (smoke inhalation with pulmonary insufficiency)
- Acute or chronic cerebral vascular insufficiency
- Hepatic necrosis
- Aerobic septicemia
This list is particularly important for facilities that may be treating pressure injuries or venous stasis ulcers alongside diabetic wounds. A decubitus ulcer does not become a covered indication simply because the patient also has diabetes—the wound must be attributable to diabetes and meet the Wagner and standard-therapy-failure criteria.
Benefit Category and Billing Site Context
CMS covers HBO therapy under three benefit categories:
- Incident to a physician's professional service
- Outpatient hospital services incident to a physician's service
- Physicians' services
This matters for billing teams managing multiple sites. Hospital outpatient departments, freestanding wound care centers billing under a physician's service, and physician offices each have distinct billing pathways. Confirm that your facility type aligns with the applicable benefit category before submitting claims.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
Affected Codes
The updated NCD 12 policy document does not list specific CPT or HCPCS codes. Billing teams should reference their MAC's local billing guidelines and the CMS Medicare Claims Processing Manual for the applicable procedure codes associated with HBO therapy chamber services. Do not assume codes from prior policy versions remain unchanged—verify with your MAC directly following the March 12, 2026 effective date.
What Your Billing Team Should Do
| # | Action Item |
|---|---|
| 1 | Audit all active HBO therapy cases immediately. Cross-reference each active patient's diagnosis against the 15 covered conditions in NCD 12. Any case where the primary indication falls outside this list should be flagged for clinical review before the next claim submission. |
| 2 | Verify Wagner grade documentation for every diabetic wound case. Wagner grade III or higher is a hard coverage requirement. If the wound care chart documents Wagner grade II and no upgrade is clinically supported, that claim will not survive an audit. Work with your clinical team to ensure wound assessments are being formally graded and documented at each visit. |
| 3 | Build a 30-day evaluation trigger into your workflow. Set a recurring review point for all active HBO patients at 30-day intervals. Document measurable healing signs (or their absence) explicitly. If healing is not measurable within a 30-day treatment window, pause billing and initiate a clinical review before submitting further claims. |
| 4 | Confirm that adjunctive therapy requirements are documented. For conditions where HBO is only covered as adjunctive therapy—crush injuries, osteoradionecrosis, actinomycosis, and others—your records must reflect that concurrent standard treatment is occurring. A standalone HBO treatment note without evidence of adjunctive use is a denial waiting to happen. |
| 5 | Verify your benefit category alignment with your billing site. Confirm whether your facility is billing under the outpatient hospital, physician's service, or incident-to pathway, and ensure your claim form and modifiers reflect that accurately ahead of the March 12, 2026 effective date. |
| 6 | Contact your MAC for applicable HBO procedure codes. Since NCD 12 does not enumerate specific CPT or HCPCS codes, reach out to your Medicare Administrative Contractor for current billing code guidance and any local coverage determination (LCD) that may apply alongside this NCD. |
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.